Synaptogenix Inc (SNPX)

[XenaLives]

And all of that is irrelevant to Anavex.. so you are cherry picking when you say it is.

My point is that with bryostatin you know the gamble. You know what the FDA is allowing. You know what the SOC score is. You know we have surpassed that already in a smaller trial (albeit with 94% patients improvement), you know when to expect results. You know its been proven safe and tolerable by FDA standards for years. You know that the FDA mandated neuroimaging in the screening process, etc. That's not cherry picking facts IMO. That's mitigating risks.